About Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
Market Cap
$3.21B
Employees
437
Listed Since
July 18, 2018
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.crinetics.comPhone
858-450-6464
Headquarters
10222 BARNES CANYON ROAD, BLDG. #2
SAN DIEGO, CA 92121
CIK
0001658247